AGT and cardiac hypertrophy: Knocking out SYT1 in vivo or silencing SYT1 in vitro respectively exacerbated TAC- or Ang II-induced cardiac injury including cardiac hypertrophy, fibrosis, dysfunction and cardiomyocyte hypertrophy and apoptosis, suggesting a protective role of SYT1 in cardiac hypertrophy.